Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2, Open-label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With
Brief Summary: This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX131� in subjects with relapsed or refractory solid tumors.